SL Science Holding Ltd (SLBT)

• Market cap: $2.05B
• 1 day: -7.83%
• 5 days: -39.17%
• 1 month: 9.61%
• 3 months: 9.61%
• 6 months: 9.61%
• Year to date: 9.61%
• 1 year: 9.61%
• 5 years: 9.61%
• 10 years: 9.61%
• Sector: Healthcare
• Industry: Biotechnology

About: SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Employees: 20